Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anette Sommer

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Cancer Medicine|December 11, 2014
Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cisJulia C Meier, Bernard Haendler, Henrik Seidel, et al.
Molecular & Cellular Proteomics : MCP|October 15, 2003
Comparison of proteomic and genomic analyses of the human breast cancer cell line T47D and the antiestrogen-resistant derivative T47D-rMartina Huber, Inke Bahr, Jörn R Krätzschmar, et al.
Bioconjugate Chemistry|July 16, 2020
Tailored Linker Chemistries for the Efficient and Selective Activation of ADCs with KSPi PayloadsHans-Georg Lerchen, Beatrix Stelte-Ludwig, Anette Sommer, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 15, 2019
Antibody-Prodrug Conjugates with KSP Inhibitors and Legumain-Mediated Metabolite FormationHans-Georg Lerchen, Beatrix Stelte-Ludwig, Sandra Berndt, et al.
Molecular Endocrinology (Baltimore, Md.)|July 4, 2009
DNA binding by estrogen receptor-alpha is essential for the transcriptional response to estrogen in the liver and the uterusDörthe L Ahlbory-Dieker, Brenda D Stride, Gabriele Leder, et al.
Targeted Oncology|September 11, 2019
First-in-Human Phase I Study of Aprutumab Ixadotin, a Fibroblast Growth Factor Receptor 2 Antibody-Drug Conjugate (BAY 1187982) in Patients with Advanced CancerSung-Bae Kim, Funda Meric-Bernstam, Aparna Kalyan, et al.
The American Journal of Pathology|May 2, 2025
Identification of a Growth-Promoting Gene Cluster in the Region 2q24 as a Driver of Tumorigenesis in Childhood HepatoblastomaMartin M Rodemann, Verena Dreschmann, Evelyn Dörner, et al.
Angewandte Chemie (International Ed. in English)|September 5, 2018
Antibody-Drug Conjugates with Pyrrole-Based KSP Inhibitors as the Payload ClassHans-Georg Lerchen, Sven Wittrock, Beatrix Stelte-Ludwig, et al.
Frontiers in Oncology|June 1, 2012
Evaluation of activity and combination strategies with the microtubule-targeting drug sagopilone in breast cancer cell linesJulia Eschenbrenner, Sebastian Winsel, Stefanie Hammer, et al.
International Journal of Colorectal Disease|April 6, 2011
Molecular profiles and clinical outcome of stage UICC II colon cancer patientsJörn Gröne, Dido Lenze, Vindi Jurinovic, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Cancer Medicine|December 11, 2014
Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cisJulia C Meier, Bernard Haendler, Henrik Seidel, et al.
Molecular & Cellular Proteomics : MCP|October 15, 2003
Comparison of proteomic and genomic analyses of the human breast cancer cell line T47D and the antiestrogen-resistant derivative T47D-rMartina Huber, Inke Bahr, Jörn R Krätzschmar, et al.
Bioconjugate Chemistry|July 16, 2020
Tailored Linker Chemistries for the Efficient and Selective Activation of ADCs with KSPi PayloadsHans-Georg Lerchen, Beatrix Stelte-Ludwig, Anette Sommer, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 15, 2019
Antibody-Prodrug Conjugates with KSP Inhibitors and Legumain-Mediated Metabolite FormationHans-Georg Lerchen, Beatrix Stelte-Ludwig, Sandra Berndt, et al.
Molecular Endocrinology (Baltimore, Md.)|July 4, 2009
DNA binding by estrogen receptor-alpha is essential for the transcriptional response to estrogen in the liver and the uterusDörthe L Ahlbory-Dieker, Brenda D Stride, Gabriele Leder, et al.
Targeted Oncology|September 11, 2019
First-in-Human Phase I Study of Aprutumab Ixadotin, a Fibroblast Growth Factor Receptor 2 Antibody-Drug Conjugate (BAY 1187982) in Patients with Advanced CancerSung-Bae Kim, Funda Meric-Bernstam, Aparna Kalyan, et al.
The American Journal of Pathology|May 2, 2025
Identification of a Growth-Promoting Gene Cluster in the Region 2q24 as a Driver of Tumorigenesis in Childhood HepatoblastomaMartin M Rodemann, Verena Dreschmann, Evelyn Dörner, et al.
Angewandte Chemie (International Ed. in English)|September 5, 2018
Antibody-Drug Conjugates with Pyrrole-Based KSP Inhibitors as the Payload ClassHans-Georg Lerchen, Sven Wittrock, Beatrix Stelte-Ludwig, et al.
Frontiers in Oncology|June 1, 2012
Evaluation of activity and combination strategies with the microtubule-targeting drug sagopilone in breast cancer cell linesJulia Eschenbrenner, Sebastian Winsel, Stefanie Hammer, et al.
International Journal of Colorectal Disease|April 6, 2011
Molecular profiles and clinical outcome of stage UICC II colon cancer patientsJörn Gröne, Dido Lenze, Vindi Jurinovic, et al.
Pageof 4